Πλοήγηση ανά Συγγραφέα "Kousoulakou, H."
-
Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: A cost effectiveness study
Geitona, M.; Kousoulakou, H.; Ollandezos, M.; Athanasakis, K.; Papanicolaou, S.; Kyriopoulos, I. (2008)Background: To compare the costs and effects of paliperidone extended release (ER), a new pharmaceutical treatment for the management of schizophrenia, with the most frequently prescribed oral treatments in Greece (namely ... -
Erratum: Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: A cost effectiveness study (Annals of General Psychiatry)
Geitona, M.; Kousoulakou, H.; Ollandezos, M.; Athanasakis, K.; Kyriopoulos, I.; Papanicolaou, S. (2009) -
Generic medicines: Greek physicians' perceptions and prescribing practices
Tsiantou, V.; Zavras, D.; Kousoulakou, H.; Geitona, M.; Kyriopoulos, J. (2009)P>Background and objective: The penetration of generic drugs in the Greek pharmaceutical market is placed among the weakest in the EU. The Greek regulatory framework does not systematically support the development of this ... -
HELSPOR'S ASSESSMENT OF THE PHARMACEUTICAL POLICY REFORMS IN GREECE: COST-CONTAINMENT AND ECONOMIC EVALUATION CRITERIA
Kousoulakou, H.; Papanicolaou, S.; Geitona, M. (2009)